home : product : imedconsent PE
 

 



Welcome Medical Protective Policyholders:

Informed Consent
The American Medical Association notes that informed consent is more than simply getting a patient to sign a written consent form.  It is a process of communication between a patient and physician that results in the patient's authorization or agreement to undergo a specific medical intervention.  For additional guidance on informed consent, please refer to the informed consent recommendations listed below.

iMedConsent™ PE
The iMedConsent™ PE application is an automated patient communication and documentation tool that produces procedure-specific consent forms, drawn from a comprehensive library of informed consent documents, that detail the treatments contemplated by individual patients. The iMedConsent™ PE application also includes patient education documents, common forms for use in the practice, information sheets for prescription and over-the-counter medications, and an extensive image gallery that allows the provider to annotate images and simplify complex topics. The iMedConsent™ application is also available in versions that meet the needs of hospitals and large, multi-specialty group practices.

Special Offer for MedPro Policyholders 
By special arrangement with The Medical Protective Company, the iMedConsent™ PE application is available to MedPro Policyholders at a 30% discount. The discount will apply both to new orders and to annual subscription renewal rates. Discounts to be computed automatically at the time of purchase.

  • List Price: $695.00 (Year 1 - single physician) MedPro Policyholder Price: $486.50
  • List Price: $295.00 (Annual content renewal) MedPro Policyholder Price: $206.50

A free 30-day evaluation of the iMedConsent™ PE application is available.

Product Features
iMedConsent™ PE assists physicians in solo or small group practice in standardizing and automating the informed consent process and other important disclosures.

Standard features of iMedConsent™ PE include:

  • Comprehensive content library in English and Spanish for a single specialty updated quarterly via web-based updates.
  • Includes network configuration capability.

For over 10 years the iMedConsent™ PE application or its precursor versions has been the standard of care for informed consent for thousands of physicians. Many of those providers have volunteered testimonials.

Product brochure  (requires adobe acrobat)

For support or registration, please use the Support Site or Contact Us. Existing users requiring support can review our support policy online.


Informed Consent Recommendations

  • Informed consent is more than a signature on a form; it is a process that defines the expectations and responsibilities of the physician and patient.

  • The informed consent process should occur well in advance of the treatment or procedure – preferably in the physician’s office and not in the pre-operative holding area. 

  • The informed consent process should include a thorough discussion of all significant risks (including death), anticipated benefits, and alternatives to treatment, explained in language the patient can understand.

  • Anesthesia risks should be addressed as separate issues, with the specific risks, anticipated benefits and alternatives explained.

  • The patient has a right to refuse any or all parts of the proposed treatment or procedure.

  • The informed consent process should always be recorded as a note in the patient record, in addition to inclusion of the signed consent form.  That note should include an assessment of the patient’s understanding.

  • While the physician’s staff may assist with aspects of patient education, the actual achievement of consent to treatment is the physician’s non-delegable duty.

  • Written materials, models, pictures and videos may be used to facilitate the informed consent process.

  • The patient should receive a copy of any informed consent forms after she/he signs them.

  • Ensure the patient is competent to provide meaningful consent to treatment, including being adequately “health literate.”  If the patient is not competent, the patient’s legal surrogate must provide consent.  The relationship of the surrogate to the patient should be noted on both the consent form and in the note.

  • If a translator assists with the informed consent process, his or her name and role should be documented on both the consent form and in the note.

 

Copyright © 2000 - 2008 by iMedConsent LLC. All rights reserved.
Terms and Conditions | Privacy Policy